BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11133544)

  • 1. Bone marrow transplantation in patients with multiple myeloma: prognostic significance of MR imaging.
    Lecouvet FE; Dechambre S; Malghem J; Ferrant A; Vande Berg BC; Maldague B
    AJR Am J Roentgenol; 2001 Jan; 176(1):91-6. PubMed ID: 11133544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
    Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
    AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
    Lecouvet FE; Vande Berg BC; Michaux L; Malghem J; Maldague BE; Jamart J; Ferrant A; Michaux JL
    Radiology; 1998 Dec; 209(3):653-60. PubMed ID: 9844655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma: MR patterns of response to treatment.
    Moulopoulos LA; Dimopoulos MA; Alexanian R; Leeds NE; Libshitz HI
    Radiology; 1994 Nov; 193(2):441-6. PubMed ID: 7972760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease.
    Moulopoulos LA; Varma DG; Dimopoulos MA; Leeds NE; Kim EE; Johnston DA; Alexanian R; Libshitz HI
    Radiology; 1992 Dec; 185(3):833-40. PubMed ID: 1438772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.
    Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Raab MS; Hillengass M; Wagner B; Jauch A; Hose D; Weber MA; Delorme S; Goldschmidt H; Hillengass J
    Haematologica; 2015 Jun; 100(6):818-25. PubMed ID: 25795721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
    Moulopoulos LA; Dimopoulos MA; Kastritis E; Christoulas D; Gkotzamanidou M; Roussou M; Koureas A; Migkou M; Gavriatopoulou M; Eleutherakis-Papaiakovou E; Gika D; Koutoulidis V; Terpos E
    Am J Hematol; 2012 Sep; 87(9):861-4. PubMed ID: 22641455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis.
    Van de Berg BC; Lecouvet FE; Michaux L; Labaisse M; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
    Radiology; 1996 Oct; 201(1):243-6. PubMed ID: 8816551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation.
    Gahrton G; Tura S; Ljungman P; Belanger C; Brandt L; Cavo M; Facon T; Granena A; Gore M; Gratwohl A
    N Engl J Med; 1991 Oct; 325(18):1267-73. PubMed ID: 1922221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images.
    Mirowitz SA; Apicella P; Reinus WR; Hammerman AM
    AJR Am J Roentgenol; 1994 Jan; 162(1):215-21. PubMed ID: 8273669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow.
    Lecouvet FE; Malghem J; Michaux L; Michaux JL; Lehmann F; Maldague BE; Jamart J; Ferrant A; Vande Berg BC
    Radiology; 1997 Jul; 204(1):201-5. PubMed ID: 9205247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of multiple myeloma in tumour mass measurement at diagnosis and during treatment.
    Carlson K; Aström G; Nyman R; Ahlström H; Simonsson B
    Acta Radiol; 1995 Jan; 36(1):9-14. PubMed ID: 7833177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S; Abdelhalim AN; Derby L; Mashtare TL; Miller KC; Wilding GE; Alberico RA; Gottlieb R; Klippenstein DL; Lee K; Chanan-Khan AA
    Cancer; 2010 Jan; 116(1):84-92. PubMed ID: 19862816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
    Hillengass J; Wasser K; Delorme S; Kiessling F; Zechmann C; Benner A; Kauczor HU; Ho AD; Goldschmidt H; Moehler TM
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):475-81. PubMed ID: 17255268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings.
    Baur A; Bartl R; Pellengahr C; Baltin V; Reiser M
    Cancer; 2004 Dec; 101(11):2599-604. PubMed ID: 15503306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma.
    Bakkus MH; Bouko Y; Samson D; Apperley JF; Thielemans K; Van Camp B; Benner A; Goldschmidt H; Moos M; Cremer FW
    Br J Haematol; 2004 Sep; 126(5):665-74. PubMed ID: 15327517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of the spine in plasma cell dyscrasias. A review.
    Pertuiset E; Bellaiche L; Lioté F; Laredo JD
    Rev Rhum Engl Ed; 1996 Dec; 63(11):837-45. PubMed ID: 9010972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
    Takashima S; Sone S; Horii A; Okamoto S; Yoshida J
    AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.